Oral cholera vaccine safety study for healthy adults
Part of Infections clinical trials.
This trial tests a new oral vaccine designed to protect against cholera. It is for healthy adults aged 18-45 who want to help evaluate the vaccine's safety and immune response. Participation involves receiving the vaccine and attending follow-up visits.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 18 and 45 years old
- Be in good general health
- Have a Swedish or other nationality identity card
- Avoid antacids or acid-reducing medications before and after each vaccine dose
- If female, not be pregnant or planning pregnancy and use birth control; if male, use birth control
- Not have received a cholera vaccine before or any other vaccine within the past 4 weeks
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an oral cholera vaccine called PanChol in healthy adults. The goal is to see if it's safe and how the body responds. It may help protect against cholera, a serious diarrheal illness.
This trial is for children aged 2 to 14 who have not had a cholera vaccine before. It tests a safe, oral vaccine to prevent cholera, a serious diarrheal disease.
This trial tests a new cholera vaccine in healthy people ages 1 to 45. It aims to see if the vaccine is safe and creates a good immune response.
This trial tests a new cholera vaccine (Biovac OCV-S) to see if it works as well as the current vaccine (Euvichol-Plus). It is for healthy people aged 1 to 45, and also for adults with HIV who are on treatment.
This study tests an oral cholera vaccine to see how it affects your gut bacteria, inflammation, and bowel habits. Participation may help researchers understand how the vaccine works in real-world populations.
This trial tests giving the oral cholera vaccine on a longer dosing schedule than usual. It aims to see if a longer gap between doses still works well to protect people from cholera, especially helpful in places where returning for a second dose is hard.
Hear when a new Cholera Vaccination Reaction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.